Top News

• No Broad FDA Reorganization Coming: Makary
• Senator Hawley Urges FDA Action on Mifepristone Study
• Cosco International CGMP Inspection Findings
• Bill Seeks to Kill Tax Deductions for DTC Ad Expenses
• FDA Misses Review Decision on Stealth Bio NDA
• Amazon Selling Unapproved, Misbranded Drugs: FDA
• CGMP Issues at BEO Pharmaceuticals
• Abeona Gains Approval of Resubmitted Zevaskyn